Intravenous RMP-7 increases delivery of ganciclovir into rat brain tumors and enhances the effects of herpes simplex virus thymidine kinase gene therapy.
LeMay, D R
Intravenous RMP-7 increases delivery of ganciclovir into rat brain tumors and enhances the effects of herpes simplex virus thymidine kinase gene therapy. [electronic resource] - Human gene therapy May 1998 - 989-95 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1043-0342
10.1089/hum.1998.9.7-989 doi
3T3 Cells
Animals
Antiviral Agents--pharmacology
Blood-Brain Barrier
Bradykinin--analogs & derivatives
Brain Neoplasms--therapy
Cell Division--drug effects
Drug Synergism
Ganciclovir--pharmacology
Genetic Therapy
Glioma--therapy
Infusions, Intravenous
Mice
Neoplasms, Experimental
Rats
Rats, Sprague-Dawley
Simplexvirus--enzymology
Thymidine Kinase--genetics
Tumor Cells, Cultured
Intravenous RMP-7 increases delivery of ganciclovir into rat brain tumors and enhances the effects of herpes simplex virus thymidine kinase gene therapy. [electronic resource] - Human gene therapy May 1998 - 989-95 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1043-0342
10.1089/hum.1998.9.7-989 doi
3T3 Cells
Animals
Antiviral Agents--pharmacology
Blood-Brain Barrier
Bradykinin--analogs & derivatives
Brain Neoplasms--therapy
Cell Division--drug effects
Drug Synergism
Ganciclovir--pharmacology
Genetic Therapy
Glioma--therapy
Infusions, Intravenous
Mice
Neoplasms, Experimental
Rats
Rats, Sprague-Dawley
Simplexvirus--enzymology
Thymidine Kinase--genetics
Tumor Cells, Cultured